Showing 1,961 - 1,980 results of 106,037 for search '(( 2 c decrease ) OR ( 5 ((((step decrease) OR (mean decrease))) OR (we decrease)) ))', query time: 1.47s Refine Results
  1. 1961

    Flowchart of data preprocessing steps. by Ehsan Yaghmaei (16985784)

    Published 2023
    “…<div><p>Alzheimer’s disease is the most common type of dementia that currently affects over 6.5 million people in the U.S. Currently there is no cure and the existing drug therapies attempt to delay the mental decline and improve cognitive abilities. …”
  2. 1962
  3. 1963
  4. 1964

    Peripheral Erythrocytes Decrease upon Specific Respiratory Challenge with Grass Pollen Allergen in Sensitized Mice and in Human Subjects by Galateja Jordakieva (512458)

    Published 2014
    “…<div><p>Background and Aims</p><p>Specific hyper-responsiveness towards an allergen and non-specific airway hyperreactivity both impair quality of life in patients with respiratory allergic diseases. We aimed to investigate cellular responses following specific and non-specific airway challenges locally and systemically in i) sensitized BALB/c mice challenged with grass pollen allergen Phl p 5, and in ii) grass pollen sensitized allergic rhinitis subjects undergoing specific airway challenge in the Vienna Challenge Chamber (VCC).…”
  5. 1965
  6. 1966
  7. 1967

    <i>Fgfr2<sup>+/S252W</sup></i> mice had shortened bone length and decreased bone mass compared with wild-type mice. by Peng Chen (6514)

    Published 2014
    “…<p>(A–F) X-ray analyses of femora, tibia and lumbar vertebrae from WT and MT mice at P5 (A, B), P10 (C, D) and P28 (E, F) revealed shorter bone length and lower bone density in mutant mice. …”
  8. 1968
  9. 1969
  10. 1970
  11. 1971

    Supplementary Material for: Decrease of Hyperintense Vessels on Fluid-Attenuated Inversion Recovery Predicts Good Outcome in t-PA Patients by Sakuta K. (4147642)

    Published 2016
    “…However, the clinical meaning of changes in HV is yet to be clarified. Here, we investigated serial changes to HV in patients with AIS who received tissue plasminogen activator (t-PA) therapy. …”
  12. 1972

    Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

    Published 2013
    “…<p>Rh4 and RMS13 cells were treated for 24 hours (A) and 48 hours (B) with different concentrations of fenretinide (0.5–1–5 µM, as indicated). PAX3/FOXO1, AP2ß, FGFR2 and FGFR4 mRNA expression levels were measured with qRT–PCR. …”
  13. 1973
  14. 1974
  15. 1975
  16. 1976
  17. 1977

    The TLR4 activator LPS decreases photoreceptor viability and reducesWnt-mediated protection from oxidative stress. by Hyun Yi (57741)

    Published 2012
    “…Mean ± SD, *p<0.05 no additions with H<sub>2</sub>O<sub>2</sub> (n = 5) compared with Wnt3a (n = 4); #p<0.05 50 µg/ml LPS+Wnt3a (n = 5) compared with Wnt3a+ H<sub>2</sub>O<sub>2</sub> (n = 4). …”
  18. 1978

    Antagonizing BMP type I receptors decreases cell growth, proliferation, and clonogenicity of lung cancer cell lines. by Elaine Langenfeld (402034)

    Published 2013
    “…(<b>B</b>) H1299 cells cultured in SFM were treated with 1 µM DMSO or 1 µM DMH2 for 7 days and cell counts performed. (<b>C</b>) BrdU incorporation of H1299 cells treated with DMSO or 1 µM or 5 µM DMH2 for 24 and 48 hours. …”
  19. 1979
  20. 1980